165 related articles for article (PubMed ID: 6541449)
1. Disposition of [14C]aztreonam in rats, dogs, and monkeys.
Kripalani KJ; Singhvi SM; Weinstein SH; Everett DW; Bathala MS; Dean AV; Ita CE; Lawrence L; Meeker FS; Shaw JM
Antimicrob Agents Chemother; 1984 Aug; 26(2):119-26. PubMed ID: 6541449
[TBL] [Abstract][Full Text] [Related]
2. Disposition of carumonam (AMA-1080/Ro 17-2301), a new N-sulfonated monocyclic beta-lactam, in rats and dogs.
Yoshida K; Mitani M; Naeshiro I; Torii H; Tanayama S
Antimicrob Agents Chemother; 1986 Jun; 29(6):1017-24. PubMed ID: 3729358
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics of NS-105, a novel cognition enhancer. 1st communication: absorption, metabolism and excretion in rats, dogs and monkeys after single administration of 14C-NS-105.
Mukai H; Sugimoto T; Ago M; Morino A
Arzneimittelforschung; 1999 Nov; 49(11):881-90. PubMed ID: 10604039
[TBL] [Abstract][Full Text] [Related]
4. Comparative pharmacokinetics of carumonam and aztreonam in mice, rats, rabbits, dogs, and cynomolgus monkeys.
Kita Y; Fugono T; Imada A
Antimicrob Agents Chemother; 1986 Jan; 29(1):127-34. PubMed ID: 3729325
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics of the new thyrotropin releasing hormone analogue montirelin hydrate. 1st communication: plasma concentrations, metabolism and excretion after a single intravenous administration to rats, dogs and monkeys.
Sugimoto T; Hayashi T; Okita A; Morino A
Arzneimittelforschung; 1996 Feb; 46(2):106-13. PubMed ID: 8720298
[TBL] [Abstract][Full Text] [Related]
6. Metabolism and pharmacokinetics of aztreonam in healthy subjects.
Swabb EA; Singhvi SM; Leitz MA; Frantz M; Sugerman A
Antimicrob Agents Chemother; 1983 Sep; 24(3):394-400. PubMed ID: 6685455
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics of the new pyrimidine derivative NS-7, a novel Na+/Ca2+ channel blocker. 1st communication: plasma concentrations and excretions after a single intravenous 14C-NS-7 injection to rats, dogs and monkeys.
Nonaka K; Tsujioka T; Tougou K; Mukai H
Arzneimittelforschung; 2003; 53(9):612-20. PubMed ID: 14558434
[TBL] [Abstract][Full Text] [Related]
8. Metabolism of labetalol by animals and man.
Martin LE; Hopkins R; Bland R
Br J Clin Pharmacol; 1976 Aug; 3(4 Suppl 3):695-710. PubMed ID: 990152
[TBL] [Abstract][Full Text] [Related]
9. Disposition and metabolism of rifapentine, a rifamycin antibiotic, in mice, rats, and monkeys.
Emary WB; Toren PC; Mathews B; Huh K
Drug Metab Dispos; 1998 Aug; 26(8):725-31. PubMed ID: 9698285
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics and disposition of DY-9760e, a novel calmodulin antagonist, in rats and monkeys.
Tachibana S; Fujimaki Y; Tachibana M; Tanaka M; Kurata T; Okazaki O; Sudo K
Arzneimittelforschung; 2005; 55(3):135-44. PubMed ID: 15819385
[TBL] [Abstract][Full Text] [Related]
11. Disposition and metabolism of olanzapine in mice, dogs, and rhesus monkeys.
Mattiuz E; Franklin R; Gillespie T; Murphy A; Bernstein J; Chiu A; Hotten T; Kassahun K
Drug Metab Dispos; 1997 May; 25(5):573-83. PubMed ID: 9152596
[TBL] [Abstract][Full Text] [Related]
12. Metabolism of p-(cyclopropylcarbonyl)phenylacetic acid (SQ 20,650). Species Differences.
Lan SJ; El-Hawey AM; Dean AV; Schreiber EC
Drug Metab Dispos; 1975; 3(3):171-9. PubMed ID: 238816
[TBL] [Abstract][Full Text] [Related]
13. Biotransformation of [14C]dasatinib: in vitro studies in rat, monkey, and human and disposition after administration to rats and monkeys.
Christopher LJ; Cui D; Li W; Barros A; Arora VK; Zhang H; Wang L; Zhang D; Manning JA; He K; Fletcher AM; Ogan M; Lago M; Bonacorsi SJ; Humphreys WG; Iyer RA
Drug Metab Dispos; 2008 Jul; 36(7):1341-56. PubMed ID: 18420785
[TBL] [Abstract][Full Text] [Related]
14. Distribution of [14C]aztreonam in rat tissue.
Singhvi SM; Ita CE; Shaw JM; Migdalof BH
Antimicrob Agents Chemother; 1984 Aug; 26(2):127-31. PubMed ID: 6541450
[TBL] [Abstract][Full Text] [Related]
15. Blood level, distribution, excretion, and metabolite pattern of [14C]-brotizolam in the rat, dog, and rhesus monkey.
Bechtel WD; Mierau J; Richter I; Stiasni M
Arzneimittelforschung; 1986 Mar; 36(3A):568-74. PubMed ID: 3718579
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics of 4-acetylaminophenylacetic acid. 1st communication: absorption, distribution, metabolism and excretion in mice, rats, dogs and monkeys after single administration of 14C-labeled compound.
Sugihara K; Morino A; Nomura A; Iida S; Sugiyama M
Arzneimittelforschung; 1990 Jul; 40(7):800-5. PubMed ID: 2222556
[TBL] [Abstract][Full Text] [Related]
17. The disposition and urinary metabolism of 14C-labelled FCE 22891, a pro-drug of FCE 22101, in animals.
Battaglia R; Benedetti MS; Frigerio E; Vicario G; Roncucci R
J Antimicrob Chemother; 1990 Jan; 25(1):133-9. PubMed ID: 2318748
[TBL] [Abstract][Full Text] [Related]
18. Metabolism and excretion of a new antianxiety drug candidate, CP-93,393, in cynomolgus monkeys: identification of the novel pyrimidine ring cleaved metabolites.
Prakash C; Cui D
Drug Metab Dispos; 1997 Dec; 25(12):1395-406. PubMed ID: 9394030
[TBL] [Abstract][Full Text] [Related]
19. Comparative metabolism of radiolabeled muraglitazar in animals and humans by quantitative and qualitative metabolite profiling.
Zhang D; Wang L; Raghavan N; Zhang H; Li W; Cheng PT; Yao M; Zhang L; Zhu M; Bonacorsi S; Yeola S; Mitroka J; Hariharan N; Hosagrahara V; Chandrasena G; Shyu WC; Humphreys WG
Drug Metab Dispos; 2007 Jan; 35(1):150-67. PubMed ID: 17062777
[TBL] [Abstract][Full Text] [Related]
20. Biotransformation of nevirapine, a non-nucleoside HIV-1 reverse transcriptase inhibitor, in mice, rats, rabbits, dogs, monkeys, and chimpanzees.
Riska PS; Joseph DP; Dinallo RM; Davidson WC; Keirns JJ; Hattox SE
Drug Metab Dispos; 1999 Dec; 27(12):1434-47. PubMed ID: 10570025
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]